FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileOaktree Acquisition Corp. III Life Sciences Unit
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
OACCU
Oaktree Acquisition Corp. III Life Sciences Unit Stock AnalysisComprehensive stock analysis for Oaktree Acquisition Corp. III Life Sciences Unit (OACCU) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisOACCU
OACCU
Oaktree Acquisition Corp. III Life Sciences Unit
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
OACCU
  1. Home
  2. Stocks
  3. Oaktree Acquisition Corp. III Life Sciences Unit

Oaktree Acquisition Corp. III Life Sciences Unit

🇺🇸OACCU•NASDAQ

Oaktree Acquisition Corp. III Life Sciences Unit

🇺🇸OACCU•NASDAQ
Market cap
$262.78M
Sentiment

Your view on OACCU

Mkt Cap
$262.78M
Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Oaktree Acquisition Corp. III Life Sciences Unit

Industry
Shell Companies
Sector
Financial Services
CEO
Zaid Pardesi
Headquarters
333 South Grand Avenue, Los Angeles, CA, US
Industry
Shell Companies
Sector
Financial Services
CEO
Zaid Pardesi
Headquarters
333 South Grand Avenue, Los Angeles, CA, US
Description

Oaktree Acquisition Corp. III Life Sciences operates as a special purpose acquisition company (SPAC). Its primary objective is to execute a strategic business combination—such as a merger, an exchange of capital stock, an asset or stock acquisition, or a broader corporate restructuring—with one or more existing enterprises.

Established in 1995, this company maintains its principal office in Los Angeles, California.

Financial Data

Stock Data

Price chart, volume, and trading data.

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for Oaktree Acquisition Corp. III Life Sciences Unit from FRC's valuation model, read against the market price. OACCU last traded at $10.76, 58.4× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Oaktree Acquisition Corp. III Life Sciences Unit. Starting points for Oaktree Acquisition Corp. III Life Sciences Unit: P/E 58.4, EPS $0.23, beta -0.03 — an Shell Companies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Oaktree Acquisition Corp. III Life Sciences Unit. Oaktree Acquisition Corp. III Life Sciences Unit does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Oaktree Acquisition Corp. III Life Sciences Unit. Trailing twelve-month EPS for Oaktree Acquisition Corp. III Life Sciences Unit stands at $0.23. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Oaktree Acquisition Corp. III Life Sciences Unit. Oaktree Acquisition Corp. III Life Sciences Unit has reported as a listed company since 2024. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold OACCU19 companies
Compare OACCU with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis

Peer companies

Market cap

  • BACCBlue Acquisition Corp.Shell Companies$292M
  • BDCIUBTC Development Corp. UnitShell Companies$267M
  • GIWWUGigCapital8 Corp. UnitsShell Companies$235M
  • KOYNCSLM Digital Asset Acquisition Corp III Class A Ordinary SharesShell Companies$246M
  • NEWTNewtekOne, Inc.Banks - Regional$303M
  • NHICNewHold Investment Corp IIIShell Companies$239M
  • TLNCUTalon Capital Corp.Shell Companies$267M

More Shell Companies companies

  • GSRFGSR IV Acquisition Corp. Class A ordinary shareNASDAQ$244M
  • GSRFRGSR IV Acquisition Corp. RightsNASDAQ$244M
  • GSRFUGSR IV Acquisition Corp. UnitsNASDAQ$275M
  • GSRVGSR V Acquisition Corp.NASDAQ$369M
  • GSRVRGSR V Acquisition Corp.NASDAQ$33M
  • GSRVUGSR V Acquisition Corp.NASDAQ$239M
  • GTENGores Holdings X, Inc.NASDAQ$470M
  • GTENUGores Holdings X, Inc. UnitsNASDAQ$470M
  • GTENWGores Holdings X, Inc. WarrantsNASDAQ$480M
  • GTERUGloba Terra Acquisition CorporationNASDAQ$188M
  • GUACBerto Acquisition Corp. IINASDAQ$390M
  • GUACUBerto Acquisition Corp. II UnitNASDAQ$77M
Open Comparable Analysis
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold Oaktree Acquisition Corp. III Life Sciences Unit, and how their positions are changing. At a $262.8M market value, institutional positions materially move Oaktree Acquisition Corp. III Life Sciences Unit's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Oaktree Acquisition Corp. III Life Sciences Unit executives and directors. Shares of Oaktree Acquisition Corp. III Life Sciences Unit have traded between $10.46 and $12.47 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Oaktree Acquisition Corp. III Life Sciences Unit. Coverage tracks Oaktree Acquisition Corp. III Life Sciences Unit within Shell Companies (Financial Services). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Oaktree Acquisition Corp. III Life Sciences Unit.

OACCU Analysis
Fair
Past2
Growth2
Health5
Profit1
Value1

News

Latest Market News